title: Good clinical response to imatinib mesylate in atypical thymic carcinoid With KIT overexpression.
authors.affiliation: Graduate School of Medicine, Kyoto University, Kyoto, Japan.
authors.forename: Satoshi
authors.initials: S
authors.lastname: Hamada
authors.forename: Katsuhiro
authors.initials: K
authors.lastname: Masago
authors.forename: Tadashi
authors.initials: T
authors.lastname: Mio
authors.forename: Seiichi
authors.initials: S
authors.lastname: Hirota
authors.forename: Michiaki
authors.initials: M
authors.lastname: Mishima
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D019009:Proto-Oncogene Proteins c-kit / Q000096:biosynthesis*; D011743:Pyrimidines / Q000627:therapeutic use*; D013945:Thymoma / Q000188:drug therapy* / Q000201:enzymology*; D013953:Thymus Neoplasms / Q000188:drug therapy* / Q000201:enzymology*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D019009:Proto-Oncogene Proteins c-kit